Nutriband (NTRB) Competitors

Nutriband (NASDAQ:NTRB) and RxSight (NASDAQ:RXST) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Which has more risk and volatility, NTRB or RXST?

Nutriband has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Comparatively, RxSight has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500.

Does the media refer more to NTRB or RXST?

In the previous week, RxSight had 40 more articles in the media than Nutriband. MarketBeat recorded 51 mentions for RxSight and 11 mentions for Nutriband. Nutriband's average media sentiment score of 0.12 beat RxSight's score of -0.14 indicating that Nutriband is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutriband	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
RxSight	2 Very Positive mention(s)	2 Positive mention(s)	35 Neutral mention(s)	4 Negative mention(s)	2 Very Negative mention(s)	Neutral

Do analysts rate NTRB or RXST?

Nutriband currently has a consensus price target of $13.00, suggesting a potential upside of 106.84%. RxSight has a consensus price target of $10.00, suggesting a potential upside of 22.55%. Given Nutriband's stronger consensus rating and higher possible upside, equities research analysts clearly believe Nutriband is more favorable than RxSight.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutriband	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
RxSight	2 Sell rating(s)	8 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.91

Do insiders & institutionals believe in NTRB or RXST?

19.7% of Nutriband shares are held by institutional investors. Comparatively, 78.8% of RxSight shares are held by institutional investors. 54.1% of Nutriband shares are held by insiders. Comparatively, 9.6% of RxSight shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Is NTRB or RXST more profitable?

RxSight has a net margin of -21.93% compared to Nutriband's net margin of -415.93%. RxSight's return on equity of -11.56% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutriband	-415.93%	-68.25%	-60.40%
RxSight	-21.93%	-11.56%	-10.31%

Which has higher earnings & valuation, NTRB or RXST?

Nutriband has higher earnings, but lower revenue than RxSight. RxSight is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutriband	$2.40M	29.23	-$10.48M	-$0.90	-6.98
RxSight	$147.06M	2.27	-$27.45M	-$0.80	-10.20

Summary

RxSight beats Nutriband on 8 of the 15 factors compared between the two stocks.